153 related articles for article (PubMed ID: 34628236)
21. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.
Lan Y; Chen Y; Xu X; Qiu Y; Liu S; Liu X; Liu BF; Zhang G
Eur J Med Chem; 2014 May; 79():216-30. PubMed ID: 24735647
[TBL] [Abstract][Full Text] [Related]
23. Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.
Sánchez-Fernández C; Entrena JM; Baeyens JM; Cobos EJ
Adv Exp Med Biol; 2017; 964():109-132. PubMed ID: 28315268
[TBL] [Abstract][Full Text] [Related]
24. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
Tzschentke TM; Christoph T; Kögel B; Schiene K; Hennies HH; Englberger W; Haurand M; Jahnel U; Cremers TI; Friderichs E; De Vry J
J Pharmacol Exp Ther; 2007 Oct; 323(1):265-76. PubMed ID: 17656655
[TBL] [Abstract][Full Text] [Related]
25. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
[TBL] [Abstract][Full Text] [Related]
26. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
Neumeyer JL; Bidlack JM; Zong R; Bakthavachalam V; Gao P; Cohen DJ; Negus SS; Mello NK
J Med Chem; 2000 Jan; 43(1):114-22. PubMed ID: 10633042
[TBL] [Abstract][Full Text] [Related]
28. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
[TBL] [Abstract][Full Text] [Related]
29. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
[TBL] [Abstract][Full Text] [Related]
30. Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.
Nieto FR; Cendán CM; Cañizares FJ; Cubero MA; Vela JM; Fernández-Segura E; Baeyens JM
Mol Pain; 2014 Feb; 10():11. PubMed ID: 24517272
[TBL] [Abstract][Full Text] [Related]
31. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones.
Cao X; Chen Y; Zhang Y; Lan Y; Zhang J; Xu X; Qiu Y; Zhao S; Liu X; Liu BF; Zhang G
J Med Chem; 2016 Apr; 59(7):2942-61. PubMed ID: 27003636
[TBL] [Abstract][Full Text] [Related]
33. Development of New Benzylpiperazine Derivatives as σ
Romeo G; Bonanno F; Wilson LL; Arena E; Modica MN; Pittalà V; Salerno L; Prezzavento O; McLaughlin JP; Intagliata S
ACS Chem Neurosci; 2021 Jun; 12(11):2003-2012. PubMed ID: 34019387
[TBL] [Abstract][Full Text] [Related]
34. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722
[TBL] [Abstract][Full Text] [Related]
35.
Garzón-Niño J; Cortés-Montero E; Rodríguez-Muñoz M; Sánchez-Blázquez P
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614024
[TBL] [Abstract][Full Text] [Related]
36. Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain.
Starnowska-Sokół J; Piotrowska A; Bogacka J; Makuch W; Mika J; Witkowska E; Godlewska M; Osiejuk J; Gątarz S; Misicka A; Przewłocka B
Neuropharmacology; 2020 Nov; 178():108232. PubMed ID: 32750445
[TBL] [Abstract][Full Text] [Related]
37. Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist.
Spahn V; Del Vecchio G; Rodriguez-Gaztelumendi A; Temp J; Labuz D; Kloner M; Reidelbach M; Machelska H; Weber M; Stein C
Sci Rep; 2018 Jun; 8(1):8965. PubMed ID: 29895890
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Biological Evaluation of Sigma-1 (σ
Cao X; Yao Z; Dou F; Zhang Y; Qiu Y; Zhao S; Xu X; Liu X; Liu BF; Chen Y; Zhang G
Chem Biodivers; 2019 Mar; 16(3):e1800599. PubMed ID: 30549193
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of the gerbil writhing response by mu-, kappa- and delta-opioids, and NK-1, -2 and -3 receptor antagonists.
Gallantine EL; Meert TF
Pharmacol Biochem Behav; 2004 Sep; 79(1):125-35. PubMed ID: 15388292
[TBL] [Abstract][Full Text] [Related]
40. Development of potent μ and δ opioid agonists with high lipophilicity.
Lee YS; Kulkarani V; Cowell SM; Ma SW; Davis P; Hanlon KE; Vanderah TW; Lai J; Porreca F; Vardanyan R; Hruby VJ
J Med Chem; 2011 Jan; 54(1):382-6. PubMed ID: 21128594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
